Mustang Bio Inc reports results for the quarter ended in September - Earnings Summary

Mustang Bio

12/11/2021 15:14

* Mustang Bio Inc  MBIO.OQ  reported a quarterly adjusted loss
of 19 cents​​ per share for the quarter ended in September. The
mean expectation of five analysts for the quarter was for a loss
of 18 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Mustang Bio Inc's reported EPS for the quarter was a loss
of 19 cents​.
* The mean earnings estimate of analysts had risen by
about 12.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Mustang Bio Inc shares had fallen by 7.8% this quarter and
lost 34.5% so far this year.
* The company reported a quarterly loss of $17.01 million.
* Wall Street's median 12-month price target for Mustang Bio Inc
is $11.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 12 at 03:14 p.m.
 ​All figures in US dollars unless otherwise stated